Growing Up with HIV
Elaine J. Abrams, MD
Professor of Pediatrics and Epidemiology, College of Physicians & Surgeons
Senior Research Director, ICAP at Columbia, Mailman School of Public Health
Columbia University, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2018. All rights reserved.
Elaine Abrams, Professor of Pediatrics & Epidemiology, is the Senior Director for Research at ICAP where she is responsible for the organization’s research agenda. She also leads ICAP’s programs supporting implementation of prevention of mother-to-child transmission and pediatric care and treatment services in Sub Saharan Africa. Dr. Abrams’ research interests have focused on mother-to-child HIV transmission, the natural history of pediatric HIV, and optimizing antiretroviral therapy for infants, children, adolescents and pregnant women and breastfeeding women. She is Chair of Primary Therapy Scientific Committee of the NIH-funded IMPAACT network. She co-chaired the WHO 2015 ART guidelines committee that recommended universal ART for all individuals living with HIV and added PrEP to the prevention toolkit. In the US she participates in guideline development for pediatric HIV treatment and as well as the prevention of mother-to-child transmission. In collaboration with Dr. Claude Mellins, Dr. Abrams has followed a cohort of children born to women living with HIV infection in New York City to document biomedical, psychosocial and behavioral health outcomes.
At the completion of this educational session, learners will:
- Understand the biomedical and behavioral health outcomes of adolescents and young adults living with perinatally acquired HIV infection.
- Appreciate the relative contribution of perinatal HIV versus psychosocial and contextual factors to behavioral health outcomes among adolescents and young adults with perinatally acquired HIV infection.
- Know that adolescents and young adults with perinatal HIV infection are at high risk for poor health outcomes and early mortality.
- Be able to identify potential early interventions to improve outcomes for young people with perinatal HIV infection.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
